• Aquila+ platform launched, delivering productivity, security, and AI-powered tools
• Software revenue up 34% in 2024, expected to accelerate in H2 2025
• Radiology services focus on improving margins and operational efficiency

IMEXHS Ltd, an innovative provider of medical imaging software and radiology services, held its 2025 Annual General Meeting, highlighting the launch of its new value proposition, Aquila+. Aquila+ is a major step forward for IMEXHS, delivering a leading-edge, AI-enhanced and productivity-oriented radiology software platform that is secure, scalable, and designed to set the benchmark for clinical excellence. The company's software is now deployed across 546 sites in 18 countries, serving over 3,500 radiologists. In 2024, IMEXHS saw a 34% increase in software revenue, and the management aims to accelerate that growth in 2025, particularly with the launch of Aquila+. The company has also achieved ISO 27001 certification, further strengthening its digital security credentials. In the radiology services business, IMEXHS is focused on improving margins and operational efficiency, including renegotiating key contracts at improved pricing and targeting new, high-margin deals in strategic markets. The company expects strong revenue growth and to be EBITDA and cash positive for 2025, with the majority of growth occurring in the second half of the year.

The company expects strong revenue growth and to be EBITDA and cash positive for 2025, with the majority of growth in revenue, earnings, and cash occurring in the second half. The company will provide specific guidance at the half-year.

IMEXHS is focused on delivering meaningful value through its new value proposition, Aquila+, which is built on three core pillars: 1) a leading-edge, AI-enhanced and productivity-oriented radiology software platform; 2) a proactive and responsive approach to customer service and support; and 3) seamless implementation, intuitive training, and rapid product updates. These initiatives position the company well to drive both top-line growth and stronger margins across the group.